Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial Combining Sulfasalazine and Gamma Knife Radiosurgery for Recurrent Glioblastoma

NCT04205357 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT04205357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04205357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial Combining Sulfasalazine and Gamma Knife Radiosurgery for Recurrent Glioblastoma
Lead sponsor
Haukeland University Hospital
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2020
Completion date
October 14, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, glioma, recurrent glioblastoma